A few months after a key label expansion, AstraZeneca’s asthma treatment Fasenra has received FDA approval to treat a rare ...
Insilico Medicine reported Phase 2a results for its lead program, saying the study achieved its primary endpoint of safety ...
Roivant is once again reaping the benefits of its bespoke business model. This time, it's selling Dermavant to Organon for up ...
Keytruda is already approved in more than 40 different oncology indications, but its latest label expansion is a first for ...
A second buyer has made an offer to buy the DNA sequencing company Singular Genomics Systems, potentially ...
Novo Nordisk is doubling down on its investment in genetic medicine-based biotechs, inking a new collaboration with a lipid ...
A startup in Brazil that lets people easily buy medicine online by combining a consumer-friendly experience with prescription ...
Just hours after the US Federal Reserve announced the first interest rate cut in four years, respiratory biotech Upstream Bio ...
Sens. Marco Rubio (R-FL) and Angus King (I-ME) have told the FDA that “considerable work” needs to be done to address ...
A promising new approach that could slow, stop or prevent nerves from dying may get its first test in patients next year.
The European Medicines Agency has solidified its recommendations to drugmakers that want to use single-arm designs in a ...
One of this weekend’s sleeper data presentations at Europe’s biggest oncology conference puts Pfizer in a leading position in ...